Recombinant Live-Attenuated Salmonella Vaccine for Veterinary Use
- PMID: 39771981
- PMCID: PMC11680399
- DOI: 10.3390/vaccines12121319
Recombinant Live-Attenuated Salmonella Vaccine for Veterinary Use
Abstract
Vaccination is essential for maintaining animal health, with priority placed on safety and cost effectiveness in veterinary use. The development of recombinant live-attenuated Salmonella vaccines (RASVs) has enabled the construction of balanced lethal systems, ensuring the stability of plasmid vectors encoding protective antigens post-immunization. These vaccines are particularly suitable for production animals, providing long-term immunity against a range of bacterial, viral, and parasitic pathogens. This review summarizes the progress made in this field, with a focus on clinical trials demonstrating the efficacy and commercial potential of RASVs in veterinary medicine.
Keywords: RASV; Salmonella; animal; attenuation; vaccine development.
Conflict of interest statement
The authors declare no conflicts of interest. The founding sponsors had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, and in the decision to publish the results.
Figures
References
-
- Roth J., Sandbulte M. The Role of Veterinary Vaccines in Livestock Production, Animal Health, and Public Health. In: Metwally S., Idrissi A.E., Viljoen G., editors. Veterinary Vaccines: Principles and Applications. Wiley; Hudson County, NJ, USA: 2021. pp. 1–10.
-
- Kuria J.K.N. Salmonella—Perspectives for Low-Cost Prevention, Control and Treatment. IntechOpen; London, UK: 2023. Salmonellosis in Food and Companion Animals and Its Public Health Importance.
-
- Zanella J.R.C. Zoonoses Emergentes e Reemergentes e Sua Importância Para Saúde e Produção Animal. Pesqui. Agropecuária Bras. 2016;51:510–519. doi: 10.1590/S0100-204X2016000500011. - DOI
Publication types
LinkOut - more resources
Full Text Sources
